Aspen Pharmacare Holdings Ltd. | Mutual Funds
Mutual Funds that own Aspen Pharmacare Holdings Ltd.
Harding Loevner International Equity Portfolio
6,580,875
1.44%
340,642
0.93%
06/30/2018
Foord Balanced Fund
6,099,637
1.34%
47,753
4.24%
03/31/2018
Vanguard Emerging Markets Stock Index Fund
5,611,907
1.23%
-44,030
0.14%
07/31/2018
Vanguard Total International Stock Index Fund
5,302,324
1.15%
95,573
0.03%
07/31/2018
Government Pension Fund - Global (The)
5,079,739
1.11%
-1,955,133
0.01%
12/31/2017
Emerging Markets Fund of the Genesis Group Trust for Employee
4,493,883
0.99%
711,402
1.06%
12/31/2016
Coronation Top 20 Fund
3,208,150
0.7%
1,240,615
4.71%
03/31/2018
iShares Core MSCI Emerging Markets ETF
3,175,655
0.7%
0
0.13%
09/05/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
3,145,156
0.69%
-219,942
0.01%
03/31/2018
Genesis Emerging Markets Investment Co. - Global Sub Fund
3,091,096
0.68%
-1,932,923
0.9%
12/31/2017
| Address |
Aspen Place, 9 Rydall Vale Park
Durban NL 4019
South Africa
|
|
Employees
|
- |
| Website |
http://www.aspenpharma.com |
| Updated |
07/08/2019 |
| Aspen Pharmacare Holdings Ltd. engages in the manufacture and supply of branded and generic pharmaceutical products. The firm operates through the following segments: Commercial Pharmaceuticals, Nutritionals, and Manufacturing. The Commercial Pharmaceuticals segment comprises of the Anaesthetic; Thrombosis; High Potency and Cytotoxics; and Other Commercial Pharmaceutical Brands. |
